Clinical Trial

Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

Name: Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse — clinical trial record (NCT06660017)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-24.

Trial Details

NCT Number	NCT06660017
Lead Sponsor	University of Oklahoma
Conditions	Head and Neck Cancer
Enrollment	62 participants
Start Date	2026-06
Primary Completion	2027-06 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-08